TRCT
SOPH icon

Tower Research Capital (TRC)’s SOPHiA GENETICS SOPH Stock Holding History

Tower Research Capital (TRC)’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-491
Closed -$2.34K – 5562
2025
Q3 		$2.34K Buy
+491
New +$1.69K ﹤0.01% 4647
2025
Q1 		– Sell
-339
Closed -$1.04K – 5742
2024
Q4 		$1.04K Buy
+339
New +$1.15K ﹤0.01% 5110
2024
Q3 		– Sell
-35
Closed -$160 – 5968
2024
Q2 		$160 Buy
+35
New +$171 ﹤0.01% 5436
2024
Q1 		– Sell
-669
Closed -$3.15K – 6123
2023
Q4 		$3.15K Buy
669
+602
+899% +$2.25K ﹤0.01% 5119
2023
Q3 		$171 Sell
67
-2,333
-97% -$7.4K ﹤0.01% 5674
2023
Q2 		$10.8K Buy
2,400
+1,826
+318% +$8.25K ﹤0.01% 4069
2023
Q1 		$3K Buy
+574
New +$1.86K ﹤0.01% 5240
2022
Q3 		– Sell
-528
Closed -$2K – 6453
2022
Q2 		$2K Buy
+528
New +$2.68K ﹤0.01% 5603
2022
Q1 		– Sell
-600
Closed -$8K – 6521
2021
Q4 		$8K Buy
+600
New +$8.85K ﹤0.01% 4826

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Tower Research Capital (TRC)'s SOPH Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of SOPHiA GENETICS (SOPH) in Q4 2025, closing a stake of 491 shares — an estimated $2.34K sold.

Tower Research Capital (TRC) first reported a position in SOPH in Q4 2021 and held it in 9 quarters. The position peaked at $10.8K in Q2 2023. 42 funds tracked by Wall St. Rank hold SOPH as of Q4 2025.

  • Tower Research Capital (TRC) reported no remaining SOPHiA GENETICS position as of Q4 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 491 SOPHiA GENETICS shares in Q4 2025, an estimated $2.34K.
  • Tower Research Capital (TRC) first reported a position in SOPHiA GENETICS in Q4 2021 and held it in 9 quarters.
  • Tower Research Capital (TRC)'s SOPHiA GENETICS position peaked at $10.8K in Q2 2023.
  • 42 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.